In Q1 2023, SP Group delivered its second-strongest quarterly revenues in its history but fell short of its record result set in Q1 2022. The quarter saw SP Group maintain its guidance expecting year-on-year (yoY) revenue growth of 5-15%, with an EBITDA margin of 16-19% and EBT margin of 9-12%; however, YoY revenues were down some 1.8% in Q1 2023 under weaker volumes, citing order delays within its healthcare segment. The guidance suggests growth potential in quarters to come; however, risks remain in the market relating to macroeconomic uncertainties, the war in Ukraine and higher interest rates. To learn more about SP Group, its current market conditions, valuation against its peers, and outlook moving forward, read the updated one-pager. Disclaimer: HC Andersen Capital receives payment from SP Group for a DigitalIR/corporate visibility subscription agreement./ Philip Coombes 11:00 05.05.2023.

info@inderes.fi (inderes.fi)

© Inderes Oyj. All rights reserved.